Key result
The CAPRI risk score predicts 1-year post-TAVR mortality with a fair 68% AUC.
Why the study?
Does the CAPRI risk score predict 1-year cardiovascular and all-cause mortality in patients undergoing TAVR?
Cohort (n=1,736)
Yes
Does the CAPRI risk score predict 1-year cardiovascular and all-cause mortality in patients undergoing TAVR?
Effect estimate: AUC 68% (95% CI 64% to 72%)
The CAPRI risk score, incorporating thoracic aortic calcification, provides fair prediction of 1-year mortality after TAVR and may help identify patients for whom the procedure would be futile.
May aid TAVR risk stratification; leaves open incremental value over existing scores for futility decisions.
OBJECTIVES: The aim of this study was to develop a new scoring system based on thoracic aortic calcification (TAC) to predict 1-year cardiovascular and all-cause mortality. BACKGROUND: A calcified aorta is often associated with poor prognosis after transcatheter aortic valve replacement (TAVR). A risk score encompassing aortic calcification may be valuable in identifying poor TAVR responders. METHODS: CAPRI (4 Cities for Assessing CAlcification PRognostic Impact) multicenter study included a training cohort (1,425 patients treated using TAVR between 2010 and 2014) and a contemporary test cohort (311 patients treated in 2015). TAC was measured by computed tomography pre-TAVR. CAPRI risk scores were based on the linear predictors of Cox models including TAC in addition to comorbidities and demographic, atherosclerotic disease and cardiac function factors. CAPRI scores were constructed and tested in 2 independent cohorts. RESULTS: increase in TAC was associated with a 6% increase in cardiovascular mortality and a 4% increase in all-cause mortality. The predicted and observed survival probabilities were highly correlated (slopes >0.9 for both cardiovascular and all-cause mortality). The model's predictive power was fair (AUC 68% [95% confidence interval [CI]: 64% to 72%]) for both cardiovascular and all-cause mortality. The model performed similarly in the training and test cohorts. CONCLUSIONS: The CAPRI score, which combines the TAC variable with classical prognostic factors, is predictive of 1-year cardiovascular and all-cause mortality. Its predictive performance was confirmed in an independent contemporary cohort. CAPRI scores are highly relevant to current practice and strengthen the evidence base for decision making in valvular interventions. Its routine use may help prevent futile procedures.
No takes yet. Share an insight, caveat, or question.
Lantelme et al. (2018) conducted a cohort in Transcatheter Aortic Valve Replacement (n=1,736). Thoracic aortic calcification (TAC) was evaluated on 1-year cardiovascular and all-cause mortality (AUC 68%, 95% CI 64% to 72%). The CAPRI risk score, incorporating thoracic aortic calcification, demonstrated fair predictive power for 1-year cardiovascular and all-cause mortality after TAVR (AUC 68%; 95% CI 64% to 72%).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: